The following is a press release from the City of Framingham issued today, April 13
FRAMINGHAM – The Framingham Vaccine Equity Initiative will not administer the Johnson and Johnson (J&J) vaccine until further notice.
Any clinics currently scheduled as a part of the equity initiative will use the Moderna vaccine.
The City will follow all guidelines about any use of the J&J vaccine.
The Massachusetts COVID-19 Command Response Center issued a statement today about the J&J vaccination pause: In response to today’s recommendation from the FDA and CDC to pause J&J vaccines due to an extremely rare condition reported in 6 individuals nationwide, the Department of Public Health directed all providers to immediately pause administration of the J&J vaccine until federal health experts investigate this matter. This action is being taken out of an abundance of caution as the FDA and CDC review these 6 cases, none of which are known to be linked to Massachusetts.
The FDA has reported over 6.8 million doses of J&J have been administered nationwide.
Individuals who have received a J&J vaccine should contact their physician if they have concerns